RheumaGen logo

RheumaGen Funding & Investors

RheumaGen is a gene-editing technology developing therapeutics to cure rheumatoid arthritis. It offers an HLA gene-editing platform that uses stem-cell-enriched blood to alter DNA to suppress the immune system and stop rheumatoid arthritis's abnormal immune response.

rheumagen.com

Total Amount Raised: $4,906,587

RheumaGen Funding Rounds

  • Series Unknown

    $4,906,587

Funding info provided by Diffbot.